Skip to main content

Table 4 Crude and adjusted Cox-proportional hazard regression output for the predictors of opportunistic infections among HIV -infected paediatrics at JMC, April 10–May 10, 2017

From: Abacavir versus Zidovudine-based regimens for treatment of HIV-infected children in resource limited settings: a retrospective cohort study

Variables

OIs

CHR [95%CI]

p-value

AHR[95%CI]

p-value

Yes

No

    

Sex

Male

30 (30.6

68 (69.4)

1

   

Female

28 (34.6)

53 (65.4)

0.94 [0.55–1.59]

0.810

  

Age: Median IQR

7 (4–9)

58 (32.4)

121 (67.6)

1.00 [0.91–1.09]

0.995

  

Base-line body mass index

Below 5th centile

53 (37.9)

87 (62.1)

3.63 [1.45–9.10]

0.006

  

Above 5thcentile

5 (12.8)

34 (87.2)

1

   

Weight for height

< 70%

15 (41.7)

21 (58.3)

1.34 [0.74–2.44]

0.332

  

70–85%

2 (14.3)

12 (85.7)

0.42 [0.10–1.73]

0.229

  

> 85%

41 (31.8)

88 (68.2)

1

   

In care of the child

Mother

7 (29.2)

17 (70.8)

1

   

Other

51 (32.9)

104 (67.1)

0.66 [0.28–1.54]

0.332

  

Maternal status

Live

47 (32.2)

99 (67.8)

1

   

Dead

11 (33.3)

22 (66.7)

1.17 [0.59–2.32]

0.654

  

Maternal sero-status

Unknown

6 (33.3)

12 (66.7)

0.71 [0.28–1.81]

0.476

  

Negative

52 (32.3)

109 (67.7)

1

   

Paternal status

Live

43 (32.6)

89 (67.4)

1

   

Dead

15 (31.9)

32 (68.1)

0.88 [0.48–1.62]

0.694

  

Residence

Urban

49 (36.6)

85 (63.4)

1

   

Rural

9 (20)

36 (80)

1.81 [0.885–3.69]

0.104

  

ART group

ABC

27 (31)

60 (69)

1.05 [0.62–1.76]

0.885

  

AZT

29 (31.5)

63 (68.5)

1

   

CD4 counta

162 (117–221)

58 (32.4)

121 (67.6)

0.98 [0.97–0.98]

< 0.001

0.99 [0.98–0.99]

< 0.001

Baseline Viral load

< 1000copes/ml

36 (24.7)

110 (75.3)

1

 

1

 

>1000copes/ml

19 (65.5)

10 (34.5)

2.87 [1.62–5.10]

< 0.001

1.72 [0.91–3.24]

0.094

WHO Stage

Stage I

5 (45.5)

6 (54.5)

1

   

Stage II

15 (23.4)

49 (76.6)

0.39 [0.14–1.06]

0.066

  

Stage III

31 (35.6)

56 (64.4)

0.59 [0.23–1.52]

0.276

  

Stage IV

7 (41.2)

10 (58.8)

0.80 [0.25–2.53]

0.707

  

Baseline nutritional status

Normal

4 (3.9)

98 (96.1)

1

 

1

 

SAM

54 (70.1)

23 (29.9)

28.37 [10.23–78.73]

< 0.001

15.92 [5.34–47.50]

< 0.001

TB treatment

No

46 (27.7)

120 (72.3)

1

 

1

 

Yes

12 (92.3)

1 (7.7)

8.58 [4.33–17.01]

< 0.001

2.93 [1.39–6.17]

0.005

  1. CHR Crude hazard ratio, AHR Adjusted hazard ratio, ABC Abacavir, ART antiretroviral therapy, AZT Azidothymidine, WHO world health organization, TB Tuberculosis
  2. aBaseline CD4 count expressed in median and interquartile range (IQR)